Stephen Liu
MD
Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics
Georgetown Lombardi Comprehensive Cancer Center
Sep 18, 2024
Episode
249
Soundcloud
Share
In a special episode of Lung Cancer Considered, host Dr. Stephen Liu discusses the recent FDA approval of pembrolizumab plus platinum and pemetrexed for mesothelioma, based on the phase III KEYNOTE 483 study.
Guest
Ibiayi Dagogo-Jack
MD
Thoracic Oncologist; Instructor of Medicine
Massachusetts General Hospital
Harvard Medical School
Quincy Chu
MD
Thoracic Oncologist
University of Alberta Cross Cancer Institute’s Drug Development Program
CCTG Investigational New Drug Committee Chair
